Atlas Trials

Matthew Galsky

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Matthew Galsky

RecordFirmDate
Pembrolizumab in Muscle-invasive Bladder Cancer (NCT05406713)Matthew Galsky2022-07-13
Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer (NCT03359239)Matthew Galsky2019-05-08
Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer (NCT03557918)Matthew Galsky2018-11-12
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer (NCT03451331)Matthew Galsky2018-05-10
Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations (NCT03448718)Matthew Galsky2018-04-17

Track Matthew Galsky automatically

Every clearance here is in the API, with alerts when new ones post.